Skip to main content
. 2013 Feb 9;20(3):477–481. doi: 10.1136/amiajnl-2012-001555

Table 1.

Alert groups with corresponding medications

Alert group name Medications
S/P CVA Aspirin-dipyridamole
COPD/asthma Fluticasone, fluticasone/salmeterol, tiotropium
Diabetes mellitus oral Rosiglitazone, repaglinide, pioglitazone, nateglinide, metformin, glimepiride, sulfonylureas, and combinations of these medications
Factor VIIa Coagulation factor VIIa
HTN Aliskiren, amiloride, β blockers except metoprolol-succinate and carvedilol), calcium channel blockers, clonidine, furosemide, guanfacine, methyldopa, metolazone, minoxidil, nitroprusside thiazides, triamterene, and combinations of these medications
HTN/CHF Carvedilol, hydralazine, isosorbide dinitrate, metoprolol succinate, spironolactone
HTN/BPH α Blockers
HTN/CHF/nephropathy ACE, ARB
HIV NRTIs, NtARTIs or NtRTIs, NNRTIs, protease inhibitors
Hyperlipidemia HMG-CoA reductase inhibitors, red yeast rice, niacin, fibric acids, ezetimibe, cholestyramine
Intravenous immune globulin Intravenous immune globulin (IVIG)
Osteoporosis Bisphosphonates
Ambulatory insulin Insulins
Pediatric asthma Albuterol
Proton pump inhibitors (PPI) PPI
Selective serotonin reuptake inhibitors Selective serotonin reuptake inhibitors (SSRI)
Hypothyroidism Levothyroxine; liotrix, thyroid desiccated